BODI(BODI)
BODI
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $212M | $254M | $316M |
| Low | $196M | $251M | $298M |
| High | $223M | $258M | $331M |
| EBITDA Avg | $-22M | $-26M | $-32M |
| Low | $-23M | $-26M | $-34M |
| High | $-20M | $-26M | $-31M |
| EBIT Avg | $-41M | $-50M | $-62M |
| Low | $-43M | $-50M | $-65M |
| High | $-38M | $-49M | $-58M |
| Net Income Avg | $633,047.5 | $3M | — |
| Low | $92,318 | $990,230 | — |
| High | $1M | $5M | — |
| EPS Avg | $0.07 | $0.44 | — |
| Low | $0.01 | $0.14 | — |
| High | $0.17 | $0.73 | — |
| Analysts (Rev / EPS) | 4 / 3 | 3 / 2 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $54M | $55M | $67M | $62M | $66M | $65M |
| Low | $47M | $46M | $57M | $53M | $56M | $55M |
| High | $58M | $61M | $74M | $69M | $73M | $72M |
| EBITDA Avg | $-6M | $-6M | $-7M | $-6M | $-7M | $-7M |
| Low | $-6M | $-6M | $-8M | $-7M | $-8M | $-7M |
| High | $-5M | $-5M | $-6M | $-5M | $-6M | $-6M |
| EBIT Avg | $-10M | $-11M | $-13M | $-12M | $-13M | $-13M |
| Low | $-11M | $-12M | $-15M | $-13M | $-14M | $-14M |
| High | $-9M | $-9M | $-11M | $-10M | $-11M | $-11M |
| Net Income Avg | $-277,532 | $-12,617 | $227,070 | $302,760 | $681,210 | $529,830 |
| Low | $-860,368 | $-14,363 | $181,448 | $241,930 | $544,344 | $423,378 |
| High | $111,013 | $-10,082 | $258,500 | $344,667 | $775,519 | $603,168 |
| EPS Avg | $-0.04 | $-0.00 | $0.03 | $0.04 | $0.09 | $0.07 |
| Low | $-0.11 | $-0.00 | $0.02 | $0.03 | $0.07 | $0.06 |
| High | $0.01 | $-0.00 | $0.03 | $0.05 | $0.10 | $0.08 |
| Analysts (Rev / EPS) | 4 / 3 | 3 / 1 | 3 / 1 | 2 / 1 | 2 / 1 | 3 / 1 |